CM Life Sciences II Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CMII research report →
About the company
CM Life Sciences II Inc. currently conducts no substantial business operations. Its primary goal is to complete a strategic business combination, which could involve a merger, stock or asset acquisition, or reorganization, with one or more enterprises within the life sciences field.
- CEO
- Eli Decatur Casdin
- IPO
- 2021
- HQ
- New York City, NY, US
Price Chart
- 52W High
- $14.39
- 52W Low
- $9.83
- 50D MA
- $10.97
- 200D MA
- $11.77
- Beta
- 0.00
- Avg Volume
- 66.04K
Get TickerSpark's AI analysis on CMII
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Feb 12, 26 | COLUMBUS CIRCLE 2 SPONSOR Corp LLC | buy | 265,000 |
| Feb 10, 26 | COLUMBUS CIRCLE 2 SPONSOR Corp LLC | other | 7,666,667 |
| Feb 22, 21 | CMLS Holdings II LLC | other | 6,900,000 |
| Feb 22, 21 | Cox Troy | other | 25,000 |
Our CMII coverage
Recent articles, reports, and earnings notes.
No research on CMII yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CMII report →Similar companies
Peers in the same neighborhood.